Low-dose oral minoxidil for hair loss
Part of Skin clinical trials.
This trial tests whether a low-dose oral form of minoxidil (a common hair-loss medicine) can help people with mild to severe male or female pattern baldness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with male or female pattern hair loss (androgenetic alopecia).
- You have not used any hair-loss treatments like topical minoxidil or finasteride in the last 3 months.
- You do not have other hair loss causes, such as hormonal issues, scarring, or inflammatory conditions.
- You have no known allergy to minoxidil.
- You do not have serious heart, kidney, or liver disease, and you do not have high or low blood pressure.
- You are not pregnant or breastfeeding and you are willing to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.